4,456 reports of this reaction
3.2% of all PEGINTERFERON ALFA 2A reports
#5 most reported adverse reaction
HEADACHE is the #5 most commonly reported adverse reaction for PEGINTERFERON ALFA 2A, manufactured by pharmaand GmbH. There are 4,456 FDA adverse event reports linking PEGINTERFERON ALFA 2A to HEADACHE. This represents approximately 3.2% of all 141,362 adverse event reports for this drug.
PEGINTERFERON ALFA 2A has an overall safety score of 85 out of 100. Patients taking PEGINTERFERON ALFA 2A who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among PEGINTERFERON ALFA 2A users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for PEGINTERFERON ALFA 2A:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 4,456 FDA reports for PEGINTERFERON ALFA 2A. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.2% of all adverse event reports for PEGINTERFERON ALFA 2A, making it a notable side effect.
If you experience headache while taking PEGINTERFERON ALFA 2A, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.